pharma · Colorectal Cancer · Lymphoma, Extranodal NK-T-Cell
Samsung Bioepis
Samsung Bioepis NL B.V.
Samsung Bioepis clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Yeonsu-gu, Incheon 21987, KR
- Founded
- 2012
- Employees
- 1,589
- Programs
- 24
- Drugs
- 34
- Patents
- 0
Samsung Bioepis projects
11 ClinicalTrials.gov programs sponsored by Samsung Bioepis.
Samsung Bioepis has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AZD2014
Samsung Bioepis NL B.V.
Cancer of Stomach
1 trial -
AZD9291
Samsung Bioepis NL B.V.
Non-Small Cell Lung Cancer With EGFR T790M Mutation
1 trial -
Byooviz 10 mg/ml solution for injection
Samsung Bioepis NL B.V.
Neovascular Age-Related Macular Degeneration (AMD), Macular Oedema Secondary to Retinal Vein Occlusion (RVO), Myopic Choroidal Neovascularization (mCNV)
1 trial -
Carfilzomib 56 MG [Kyprolis]
Samsung Bioepis NL B.V.
Multiple Myeloma
1 trial -
Docetaxel + Sunitinib
Samsung Bioepis NL B.V.
Advanced Gastric Cancer
1 trial -
Evogliptin
Samsung Bioepis NL B.V.
Type2 Diabetes Mellitus
1 trial -
Gemcitabine+simvastatin
Samsung Bioepis NL B.V.
Pancreatic Cancer
1 trial -
Pemetrexed
Samsung Bioepis NL B.V.
Colorectal Cancer
1 trial -
Zydena (Udenafil)
Samsung Bioepis NL B.V.
Vascular Dementia
1 trial -
avelumab
Samsung Bioepis NL B.V.
Lymphoma, Extranodal NK-T-Cell
1 trial -
vistusertib (AZD2014)
Samsung Bioepis NL B.V.
Small Cell Lung Cancer
1 trial
Frequently asked questions
How many clinical projects does Samsung Bioepis have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.